Blog

27 Oct 2022

Penn Medicine and Boston-area biopharm firm to pursue potential solid tumor CAR...

27 Oct 2022

Five life sciences trends to watch for in 2023

27 Oct 2022

A biopharma firm with a unique public-private model opens in Watertown

27 Oct 2022

Earlier this year, Cybereason was gearing up for an IPO. Now, it’s laying...

27 Oct 2022

Letter to the editor: Passing Question 1 would be an ‘economic disaster...

27 Oct 2022

BioMed marks start of work on new Takeda lab in Kendall

27 Oct 2022

DraftKings urges Gaming Commission to reconsider sports betting timeline

27 Oct 2022

Early indicators show HBCU growth while most colleges lose students

27 Oct 2022

Running shoe startup launches to help women find their perfect fit

27 Oct 2022

Boston investment firm pledges $25M for medical research in Rwanda

27 Oct 2022

Exclusive: National portfolio sale of 144 bank branches underscores opportunity...

27 Oct 2022

Early filings highlight billions in investment losses for college endowments